Gayle Furgurson Wellborn
CIK: 0001712960
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HEALTHEQUITY, INC.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 25, 2026HQY
HEALTHEQUITY, INC.
Award(A)Direct2.9K shares- - May 28, 2026HQY
HEALTHEQUITY, INC.
Exercise(M)Direct2.4K shares at avg. $47.21$115K - May 28, 2026HQY
HEALTHEQUITY, INC.
Sale(S)Direct2.4K shares at avg. $90.00$220K - Dec 12, 2025HQY
HEALTHEQUITY, INC.
Exercise(M)Direct4.3K shares at avg. $50.41$219K - Dec 12, 2025HQY
HEALTHEQUITY, INC.
Sale(S)Direct4.3K shares at avg. $98.03$425K - Jun 26, 2025HQY
HEALTHEQUITY, INC.
Award(A)Direct2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2026 | HQY HEALTHEQUITY, INC. | Award(A) | 2,877 | - | $0 | Direct |
| May 28, 2026 | HQY HEALTHEQUITY, INC. | Exercise(M) | 2,439 | $47.21 | $115,145 | Direct |
| May 28, 2026 | HQY HEALTHEQUITY, INC. | Sale(S) | 2,439 | $90.00 | $219,510 | Direct |
| Dec 12, 2025 | HQY HEALTHEQUITY, INC. | Exercise(M) | 4,339 | $50.41 | $218,729 | Direct |
| Dec 12, 2025 | HQY HEALTHEQUITY, INC. | Sale(S) | 4,339 | $98.03 | $425,331 | Direct |
| Jun 26, 2025 | HQY HEALTHEQUITY, INC. | Award(A) | 2,003 | - | - | Direct |
1-6 of 6 transactions
About Wellborn Gayle Furgurson
Wellborn Gayle Furgurson (SEC CIK 0001712960) files insider reports with the SEC as Director of HEALTHEQUITY, INC. (HQY).
Signal8 holds 4 ownership filings by Wellborn Gayle Furgurson, all Form 4s, filed between Jun 30, 2025 and Jun 29, 2026. Those filings report 6 transactions, from Jun 26, 2025 to Jun 25, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Wellborn Gayle Furgurson's filings is in DRAPER, UT.
Recent filings by Wellborn Gayle Furgurson
- Jun 25, 2026: Grant or award of HQY shares (Form 4, code A).
- May 28, 2026: Option exercise of HQY shares (Form 4, code M).
- May 28, 2026: Open-market sale of HQY shares (Form 4, code S).
- Dec 12, 2025: Option exercise of HQY shares (Form 4, code M).
- Dec 12, 2025: Open-market sale of HQY shares (Form 4, code S).
Other insiders filing for HEALTHEQUITY, INC. (HQY)
- Rajasekar Sunil, EVP Chief Prod & Strat Officer
- Ladd Delano, EVP, General Counsel
- Fiore Michael Henry, Officer
- Neeleman Stephen, FOUNDER AND VICE CHAIRMAN
- Gathright Michael, Chief Customer Officer
- Lucania James M, EVP & CFO